nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—DRD4—conduct disorder	0.597	0.684	CbGaD
Risperidone—HTR2A—conduct disorder	0.275	0.316	CbGaD
Risperidone—Paliperidone—DRD4—conduct disorder	0.00316	0.403	CrCbGaD
Risperidone—HTR7—autonomic nervous system—conduct disorder	0.00291	0.252	CbGeAlD
Risperidone—Iloperidone—DRD4—conduct disorder	0.00221	0.282	CrCbGaD
Risperidone—HTR2A—autonomic nervous system—conduct disorder	0.00181	0.157	CbGeAlD
Risperidone—Paliperidone—HTR2A—conduct disorder	0.00146	0.186	CrCbGaD
Risperidone—Iloperidone—HTR2A—conduct disorder	0.00102	0.13	CrCbGaD
Risperidone—DRD4—brain—conduct disorder	0.000895	0.0775	CbGeAlD
Risperidone—DRD3—brain—conduct disorder	0.000629	0.0545	CbGeAlD
Risperidone—ADRA1B—brain—conduct disorder	0.000483	0.0419	CbGeAlD
Risperidone—H1F0—brain—conduct disorder	0.000456	0.0395	CbGeAlD
Risperidone—DRD1—brain—conduct disorder	0.00045	0.039	CbGeAlD
Risperidone—HTR1B—brain—conduct disorder	0.000365	0.0316	CbGeAlD
Risperidone—HTR1D—brain—conduct disorder	0.000353	0.0306	CbGeAlD
Risperidone—HTR2C—brain—conduct disorder	0.00035	0.0303	CbGeAlD
Risperidone—HTR2B—brain—conduct disorder	0.000329	0.0285	CbGeAlD
Risperidone—HTR1A—brain—conduct disorder	0.000294	0.0255	CbGeAlD
Risperidone—HTR7—brain—conduct disorder	0.000281	0.0244	CbGeAlD
Risperidone—ADRA1A—brain—conduct disorder	0.000271	0.0235	CbGeAlD
Risperidone—DRD2—brain—conduct disorder	0.000266	0.0231	CbGeAlD
Risperidone—KCNH2—brain—conduct disorder	0.000262	0.0227	CbGeAlD
Risperidone—ADRA2C—brain—conduct disorder	0.000259	0.0224	CbGeAlD
Risperidone—HRH1—brain—conduct disorder	0.00021	0.0182	CbGeAlD
Risperidone—ADRA2A—brain—conduct disorder	0.000206	0.0179	CbGeAlD
Risperidone—HTR2A—brain—conduct disorder	0.000175	0.0152	CbGeAlD
Risperidone—CYP2D6—brain—conduct disorder	0.00016	0.0139	CbGeAlD
Risperidone—ABCB1—brain—conduct disorder	0.000115	0.00997	CbGeAlD
Risperidone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	9.75e-05	0.000897	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	9.73e-05	0.000895	CbGpPWpGaD
Risperidone—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.64e-05	0.000887	CbGpPWpGaD
Risperidone—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	9.64e-05	0.000887	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	9.57e-05	0.000881	CbGpPWpGaD
Risperidone—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.49e-05	0.000873	CbGpPWpGaD
Risperidone—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	9.49e-05	0.000873	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—CGA—conduct disorder	9.46e-05	0.00087	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—CGA—conduct disorder	9.13e-05	0.00084	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—CGA—conduct disorder	9.08e-05	0.000836	CbGpPWpGaD
Risperidone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.84e-05	0.000813	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—CGA—conduct disorder	8.83e-05	0.000813	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—CGA—conduct disorder	8.83e-05	0.000812	CbGpPWpGaD
Risperidone—HTR7—GPCR ligand binding—HTR2A—conduct disorder	8.77e-05	0.000807	CbGpPWpGaD
Risperidone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.75e-05	0.000805	CbGpPWpGaD
Risperidone—DRD2—GPCR ligand binding—DRD4—conduct disorder	8.75e-05	0.000805	CbGpPWpGaD
Risperidone—CYP2D6—Biological oxidations—COMT—conduct disorder	8.72e-05	0.000802	CbGpPWpGaD
Risperidone—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	8.71e-05	0.000802	CbGpPWpGaD
Risperidone—HTR7—Circadian rythm related genes—EP300—conduct disorder	8.7e-05	0.0008	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—CGA—conduct disorder	8.69e-05	0.0008	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—CGA—conduct disorder	8.68e-05	0.000799	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—CGA—conduct disorder	8.66e-05	0.000797	CbGpPWpGaD
Risperidone—CYP2D6—Biological oxidations—MAOA—conduct disorder	8.66e-05	0.000796	CbGpPWpGaD
Risperidone—HTR2A—GPCR ligand binding—DRD4—conduct disorder	8.6e-05	0.000792	CbGpPWpGaD
Risperidone—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	8.6e-05	0.000791	CbGpPWpGaD
Risperidone—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.59e-05	0.00079	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—DRD4—conduct disorder	8.59e-05	0.00079	CbGpPWpGaD
Risperidone—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	8.54e-05	0.000785	CbGpPWpGaD
Risperidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.53e-05	0.000785	CbGpPWpGaD
Risperidone—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	8.53e-05	0.000785	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	8.5e-05	0.000782	CbGpPWpGaD
Risperidone—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.49e-05	0.000781	CbGpPWpGaD
Risperidone—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.43e-05	0.000775	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	8.43e-05	0.000775	CbGpPWpGaD
Risperidone—DRD4—GPCR ligand binding—HTR2A—conduct disorder	8.39e-05	0.000772	CbGpPWpGaD
Risperidone—DRD4—Circadian rythm related genes—EP300—conduct disorder	8.32e-05	0.000766	CbGpPWpGaD
Risperidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.26e-05	0.00076	CbGpPWpGaD
Risperidone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.13e-05	0.000748	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—CGA—conduct disorder	8.01e-05	0.000737	CbGpPWpGaD
Risperidone—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	8.01e-05	0.000737	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	7.9e-05	0.000727	CbGpPWpGaD
Risperidone—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.89e-05	0.000726	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—CGA—conduct disorder	7.89e-05	0.000726	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—CGA—conduct disorder	7.87e-05	0.000724	CbGpPWpGaD
Risperidone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.83e-05	0.00072	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	7.83e-05	0.00072	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—CGA—conduct disorder	7.72e-05	0.00071	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—DRD4—conduct disorder	7.6e-05	0.000699	CbGpPWpGaD
Risperidone—DRD1—GPCR ligand binding—HTR2A—conduct disorder	7.56e-05	0.000695	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	7.55e-05	0.000694	CbGpPWpGaD
Risperidone—DRD1—Circadian rythm related genes—EP300—conduct disorder	7.49e-05	0.000689	CbGpPWpGaD
Risperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.49e-05	0.000689	CbGpPWpGaD
Risperidone—DRD3—GPCR ligand binding—HTR2A—conduct disorder	7.46e-05	0.000686	CbGpPWpGaD
Risperidone—DRD3—Circadian rythm related genes—EP300—conduct disorder	7.39e-05	0.00068	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	7.39e-05	0.00068	CbGpPWpGaD
Risperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.36e-05	0.000677	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CGA—conduct disorder	7.28e-05	0.000669	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CGA—conduct disorder	7.23e-05	0.000665	CbGpPWpGaD
Risperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.22e-05	0.000664	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—CGA—conduct disorder	7.17e-05	0.00066	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CGA—conduct disorder	7.08e-05	0.000651	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	7.02e-05	0.000646	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CGA—conduct disorder	6.97e-05	0.000641	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	6.94e-05	0.000639	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—DRD4—conduct disorder	6.9e-05	0.000635	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—DRD4—conduct disorder	6.85e-05	0.000631	CbGpPWpGaD
Risperidone—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	6.82e-05	0.000627	CbGpPWpGaD
Risperidone—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	6.73e-05	0.000619	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—DRD4—conduct disorder	6.71e-05	0.000617	CbGpPWpGaD
Risperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.71e-05	0.000617	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CGA—conduct disorder	6.65e-05	0.000612	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—DRD4—conduct disorder	6.55e-05	0.000602	CbGpPWpGaD
Risperidone—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	6.5e-05	0.000598	CbGpPWpGaD
Risperidone—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	6.47e-05	0.000595	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—DRD4—conduct disorder	6.46e-05	0.000594	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—CGA—conduct disorder	6.43e-05	0.000591	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—DRD4—conduct disorder	6.3e-05	0.00058	CbGpPWpGaD
Risperidone—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	6.29e-05	0.000579	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CGA—conduct disorder	6.27e-05	0.000577	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—CGA—conduct disorder	6.24e-05	0.000574	CbGpPWpGaD
Risperidone—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	6.19e-05	0.000569	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CGA—conduct disorder	6.19e-05	0.000569	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—DRD4—conduct disorder	5.94e-05	0.000547	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—DRD4—conduct disorder	5.87e-05	0.00054	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—WASF1—conduct disorder	5.83e-05	0.000537	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	5.83e-05	0.000537	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—WASF1—conduct disorder	5.79e-05	0.000533	CbGpPWpGaD
Risperidone—DRD2—GPCR ligand binding—HTR2A—conduct disorder	5.71e-05	0.000525	CbGpPWpGaD
Risperidone—CYP3A4—Biological oxidations—COMT—conduct disorder	5.7e-05	0.000524	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—WASF1—conduct disorder	5.67e-05	0.000522	CbGpPWpGaD
Risperidone—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.66e-05	0.000521	CbGpPWpGaD
Risperidone—DRD2—Circadian rythm related genes—EP300—conduct disorder	5.66e-05	0.000521	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	5.63e-05	0.000518	CbGpPWpGaD
Risperidone—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.62e-05	0.000517	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—HTR2A—conduct disorder	5.6e-05	0.000515	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	5.6e-05	0.000515	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CGA—conduct disorder	5.59e-05	0.000514	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—WASF1—conduct disorder	5.58e-05	0.000514	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	5.5e-05	0.000506	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	5.45e-05	0.000501	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CGA—conduct disorder	5.39e-05	0.000496	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CGA—conduct disorder	5.36e-05	0.000494	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	5.36e-05	0.000493	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—WASF1—conduct disorder	5.33e-05	0.00049	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	5.3e-05	0.000487	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CGA—conduct disorder	5.22e-05	0.00048	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CGA—conduct disorder	5.13e-05	0.000472	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—DRD4—conduct disorder	5.11e-05	0.00047	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	5.11e-05	0.00047	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—DRD4—conduct disorder	5.09e-05	0.000468	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—CGA—conduct disorder	5.07e-05	0.000466	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—WASF1—conduct disorder	5.03e-05	0.000462	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—WASF1—conduct disorder	4.96e-05	0.000456	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	4.96e-05	0.000456	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	4.95e-05	0.000455	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—DRD4—conduct disorder	4.94e-05	0.000455	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	4.92e-05	0.000453	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	4.87e-05	0.000448	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	4.86e-05	0.000447	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—DRD4—conduct disorder	4.85e-05	0.000446	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	4.82e-05	0.000444	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	4.76e-05	0.000438	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	4.74e-05	0.000437	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CGA—conduct disorder	4.73e-05	0.000436	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CGA—conduct disorder	4.66e-05	0.000429	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CGA—conduct disorder	4.65e-05	0.000428	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CGA—conduct disorder	4.64e-05	0.000427	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CGA—conduct disorder	4.56e-05	0.00042	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	4.53e-05	0.000417	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—HTR2A—conduct disorder	4.5e-05	0.000414	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—DRD4—conduct disorder	4.49e-05	0.000413	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—WASF1—conduct disorder	4.48e-05	0.000412	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	4.47e-05	0.000411	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	4.42e-05	0.000407	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.42e-05	0.000406	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—DRD4—conduct disorder	4.41e-05	0.000405	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	4.38e-05	0.000403	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	4.32e-05	0.000398	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.32e-05	0.000398	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—HTR2A—conduct disorder	4.31e-05	0.000396	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.3e-05	0.000396	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	4.27e-05	0.000393	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CGA—conduct disorder	4.24e-05	0.00039	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	4.21e-05	0.000388	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—WASF1—conduct disorder	4.18e-05	0.000385	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—WASF1—conduct disorder	4.12e-05	0.000379	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	4.11e-05	0.000378	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—DRD4—conduct disorder	4.07e-05	0.000375	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—DRD4—conduct disorder	4.05e-05	0.000372	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	4.02e-05	0.00037	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—DRD4—conduct disorder	3.96e-05	0.000365	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—HTR2A—conduct disorder	3.88e-05	0.000357	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—HTR2A—conduct disorder	3.83e-05	0.000352	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	3.8e-05	0.00035	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—WASF1—conduct disorder	3.79e-05	0.000349	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.73e-05	0.000343	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—WASF1—conduct disorder	3.73e-05	0.000343	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—DRD4—conduct disorder	3.72e-05	0.000343	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	3.67e-05	0.000338	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—WASF1—conduct disorder	3.66e-05	0.000336	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.65e-05	0.000336	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	3.65e-05	0.000336	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	3.55e-05	0.000327	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—DRD4—conduct disorder	3.51e-05	0.000323	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CGA—conduct disorder	3.5e-05	0.000322	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	3.5e-05	0.000322	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—DRD4—conduct disorder	3.46e-05	0.000319	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	3.45e-05	0.000318	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—WASF1—conduct disorder	3.4e-05	0.000313	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.34e-05	0.000307	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.32e-05	0.000305	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CGA—conduct disorder	3.3e-05	0.000304	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	3.23e-05	0.000297	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.22e-05	0.000297	CbGpPWpGaD
Risperidone—ADRA2B—Hemostasis—EP300—conduct disorder	3.19e-05	0.000293	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.18e-05	0.000292	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3.17e-05	0.000291	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—DRD4—conduct disorder	3.13e-05	0.000288	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	3.11e-05	0.000286	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—DRD4—conduct disorder	3.02e-05	0.000278	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—DRD4—conduct disorder	3e-05	0.000276	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—EP300—conduct disorder	2.98e-05	0.000274	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.93e-05	0.000269	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—DRD4—conduct disorder	2.92e-05	0.000269	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—COMT—conduct disorder	2.9e-05	0.000267	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.89e-05	0.000266	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—MAOA—conduct disorder	2.88e-05	0.000265	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—DRD4—conduct disorder	2.88e-05	0.000265	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—HTR2A—conduct disorder	2.88e-05	0.000265	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.82e-05	0.00026	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—COMT—conduct disorder	2.82e-05	0.000259	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—MAOA—conduct disorder	2.8e-05	0.000257	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—HTR2A—conduct disorder	2.66e-05	0.000245	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—DRD4—conduct disorder	2.65e-05	0.000244	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—HTR2A—conduct disorder	2.64e-05	0.000243	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.62e-05	0.000241	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.61e-05	0.00024	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—DRD4—conduct disorder	2.6e-05	0.00024	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—HTR2A—conduct disorder	2.59e-05	0.000238	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.55e-05	0.000235	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—HTR2A—conduct disorder	2.54e-05	0.000234	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HTR2A—conduct disorder	2.43e-05	0.000224	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—EP300—conduct disorder	2.42e-05	0.000223	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.37e-05	0.000218	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HTR2A—conduct disorder	2.29e-05	0.000211	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—COMT—conduct disorder	2.29e-05	0.000211	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—MAOA—conduct disorder	2.27e-05	0.000209	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HTR2A—conduct disorder	2.26e-05	0.000208	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CGA—conduct disorder	2.16e-05	0.000199	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—COMT—conduct disorder	2.1e-05	0.000193	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—MAOA—conduct disorder	2.08e-05	0.000192	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	2.04e-05	0.000188	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.97e-05	0.000181	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.96e-05	0.00018	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.91e-05	0.000175	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	1.88e-05	0.000173	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.73e-05	0.000159	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.7e-05	0.000156	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.67e-05	0.000153	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—COMT—conduct disorder	1.58e-05	0.000146	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—MAOA—conduct disorder	1.57e-05	0.000145	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.55e-05	0.000142	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—COMT—conduct disorder	1.49e-05	0.000137	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—MAOA—conduct disorder	1.48e-05	0.000136	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—EP300—conduct disorder	1.41e-05	0.00013	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—EP300—conduct disorder	1.4e-05	0.000129	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—EP300—conduct disorder	1.37e-05	0.000126	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EP300—conduct disorder	1.35e-05	0.000124	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EP300—conduct disorder	1.29e-05	0.000118	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—EP300—conduct disorder	1.24e-05	0.000114	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EP300—conduct disorder	1.21e-05	0.000112	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—EP300—conduct disorder	1.21e-05	0.000111	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EP300—conduct disorder	1.2e-05	0.00011	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EP300—conduct disorder	1.08e-05	9.95e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EP300—conduct disorder	1.04e-05	9.6e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EP300—conduct disorder	1.04e-05	9.55e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EP300—conduct disorder	1.01e-05	9.29e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EP300—conduct disorder	9.94e-06	9.15e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—EP300—conduct disorder	9.81e-06	9.03e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—COMT—conduct disorder	9.75e-06	8.97e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MAOA—conduct disorder	9.68e-06	8.9e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EP300—conduct disorder	9.16e-06	8.43e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EP300—conduct disorder	9.02e-06	8.3e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EP300—conduct disorder	9e-06	8.28e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—EP300—conduct disorder	8.99e-06	8.27e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EP300—conduct disorder	8.83e-06	8.12e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EP300—conduct disorder	8.2e-06	7.55e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—EP300—conduct disorder	6.78e-06	6.24e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—EP300—conduct disorder	6.39e-06	5.88e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—EP300—conduct disorder	4.18e-06	3.85e-05	CbGpPWpGaD
